Information Provided By: 
Fly News Breaks for January 2, 2018
GMED
Jan 2, 2018 | 07:15 EDT
As previously reported, Morgan Stanley analyst Jonathan Demchick upgraded Globus Medical to Overweight from Equal Weight, stating that he thinks its robotics opportunity is being undervalued as he believes the consensus view appreciates the system opportunity, but is not adequately accounting for the impact from implant pull-through. Demchick raised his price target on Globus shares to $48 from $32.
News For GMED From the Last 2 Days
There are no results for your query GMED
